Evidence map›Paper›PMID 25553211›Full record

ArticleSports health2015

Current concepts: the role of mesenchymal stem cells in the management of knee osteoarthritis.

Jesse I Wolfstadt, Brian J Cole, Darrell J Ogilvie-Harris, Sowmya Viswanathan, Jaskarndip Chahal

Registry-linked trialAbstract read
In one paragraph

Article in Sports health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03580148 (A Randomized Trial of Cortisone Injection Versus Bone Marrow Aspirate Injection Therapy for Glenohumeral Osteoarthritis), which is not on this map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03580148 phase2 / phase3completednot on this map

A Randomized Trial of Cortisone Injection Versus Bone Marrow Aspirate Injection Therapy for Glenohumeral Osteoarthritis

TypeinterventionalSponsorWomen's College HospitalRan2015 to 2021Enrolled34ConditionsOsteo Arthritis ShouldersArmsCortisone, Bone Marrow Aspirate
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Review
  12. Intravenous injection of adipose-derived mesenchymal stromal cells benefits gait and inflammation in a spontaneous osteoarthritis model.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jesse I WolfstadtUniversity Health Network Arthritis Program, University of Toronto, Toronto, Ontario, Canada.
Brian J ColeRush University Medical Centre, Chicago, Illinois.
Darrell J Ogilvie-HarrisUniversity Health Network Arthritis Program, University of Toronto, Toronto, Ontario, Canada ; University of Toronto Orthopaedic Sports Medicine Program, Women's College Hospital, Toronto, Ontario, Canada.
Sowmya ViswanathanCell Therapy Program, University Health Network, Toronto, Ontario, Canada.
Jaskarndip ChahalUniversity Health Network Arthritis Program, University of Toronto, Toronto, Ontario, Canada ; University of Toronto Orthopaedic Sports Medicine Program, Women's College Hospital, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe number of adults with osteoarthritis in the United States is expected to nearly double from 21.4 million in 2005 to 41.1 million by 2030. As a result, medical costs and associated comorbidity will exponentially increase in the coming decades. In the past decade, mesenchymal stem cells (MSCs) have emerged as a novel treatment for degenerative joint disease. EVIDENCE ACQUISITION: PubMed (from 1990 to 2013) was searched to identify relevant studies. Reference lists of included studies were also reviewed. STUDY

designClinical review. LEVEL OF EVIDENCE: Level 3.

resultsWe identified 9 animal and 7 human studies investigating the use of MSCs in the treatment of osteoarthritis, with varying levels of support for this therapy.

conclusionWhile MSCs have shown potential for improving function and decreasing inflammation in animal studies, translation to patients is still in question. There is a great deal of heterogeneity in treatment methods. Standardizing the manufacturing and characterization of MSCs will allow for better comparisons.

Indexed as

mesenchymal stem cellsosteoarthritistreatment

Identifiers

PMID25553211
PMCPMC4272690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.